First Trust Advisors
PGEN icon

First Trust Advisors’s Precigen PGEN Stock Holding History

First Trust Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22.5M Buy
2,623,975
+609,316
+30% +$4M 0.01% 897
2026
Q2 		$11.5M Buy
+2,014,659
New +$8.71M 0.01% 1153
2021
Q3 		– Sell
-82,488
Closed -$538K – 2603
2021
Q2 		$538K Buy
+82,488
New +$576K ﹤0.01% 2260
2019
Q4 		– Sell
-48,623
Closed -$278K – 2438
2019
Q3 		$278K Buy
+48,623
New +$330K ﹤0.01% 2299
2019
Q2 		– Sell
-11,227,790
Closed -$59.1M – 2486
2019
Q1 		$59.1M Buy
11,227,790
+4,721,782
+73% +$32.7M 0.12% 209
2018
Q4 		$42.5M Sell
6,506,008
-196,218
-3% -$2.2M 0.1% 251
2018
Q3 		$115M Buy
6,702,226
+3,491,403
+109% +$51.9M 0.21% 90
2018
Q2 		$44.8M Sell
3,210,823
-422,293
-12% -$7.13M 0.09% 249
2018
Q1 		$55.7M Buy
3,633,116
+1,384,705
+62% +$19.8M 0.13% 161
2017
Q4 		$25.9M Buy
2,248,411
+659,632
+42% +$9.8M 0.06% 425
2017
Q3 		$30.2M Buy
1,588,779
+51,691
+3% +$1.06M 0.08% 313
2017
Q2 		$37M Buy
1,537,088
+376,780
+32% +$8.26M 0.1% 231
2017
Q1 		$23M Buy
1,160,308
+149,952
+15% +$3.35M 0.06% 408
2016
Q4 		$24.3M Sell
1,010,356
-80,412
-7% -$2.24M 0.07% 370
2016
Q3 		$30.3M Buy
1,090,768
+767,012
+237% +$20.3M 0.09% 273
2016
Q2 		$7.9M Buy
323,756
+260,582
+412% +$7.39M 0.02% 779
2016
Q1 		$2.12M Sell
63,174
-405,524
-87% -$12.8M 0.01% 1272
2015
Q4 		$14M Sell
468,698
-1,145,737
-71% -$38.6M 0.04% 549
2015
Q3 		$50.9M Buy
1,614,435
+1,540,628
+2,087% +$75.2M 0.15% 143
2015
Q2 		$3.57M Buy
73,807
+15,475
+27% +$652K 0.01% 1190
2015
Q1 		$2.53M Buy
+58,332
New +$2.1M 0.01% 1364

Other funds holding PGEN

Patient Capital Management
Patient Capital Management Baltimore, Maryland $3.15B AUM 29.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Iridian Asset Management
Iridian Asset Management Westport, Connecticut $275M AUM 37.66% 1-Year Est. Return
Occam Crest Management
Occam Crest Management Darien, Connecticut $188M AUM 69.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

First Trust Advisors's PGEN Position: Q3 2026 in Review

First Trust Advisors increased its Precigen (PGEN) stake by 30% in Q3 2026, buying an estimated $4M and bringing the position to 2,623,975 shares worth $22.5M. The position accounts for 0.01% of the portfolio, ranked #897.

First Trust Advisors first reported a position in PGEN in Q1 2015 and has held it in 21 quarters since. The position peaked at $115M in Q3 2018. 183 funds tracked by Wall St. Rank hold PGEN as of Q3 2026.

  • First Trust Advisors held 2,623,975 shares of Precigen worth $22.5M as of Q3 2026.
  • First Trust Advisors bought 609,316 Precigen shares in Q3 2026, an estimated $4M.
  • Precigen made up 0.01% of First Trust Advisors's portfolio in Q3 2026, its #897 holding.
  • First Trust Advisors first reported a position in Precigen in Q1 2015 and has held it in 21 quarters since.
  • First Trust Advisors's Precigen position peaked at $115M in Q3 2018.
  • 183 funds tracked by Wall St. Rank held Precigen as of Q3 2026.

Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.